Skip to content
Current Liabilities

Deferred Revenue

Medtronic Deferred Revenue increased by 33.3% to $400M in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $400M to $400M.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ1 2019
Last reportedQ3 2026Feb 24, 2026
Metric ID: deferred_revenue_current

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$1.2B$1.1B$1B$801M$719M$662M$600M$500M$500M$400M$400M$400M$400M$300M$400M
QoQ Change-8.3%-9.1%-19.9%-10.2%-7.9%-9.4%-16.7%+0.0%-20.0%+0.0%+0.0%+0.0%-25.0%+33.3%
YoY Change-33.3%-34.6%-33.8%-25.1%-30.5%-24.5%-33.3%-20.0%-20.0%+0.0%-25.0%+0.0%
Range$300M$1.2B
CAGR-26.9%
Avg YoY Growth-23.3%
Median YoY Growth-25.0%

Frequently Asked Questions

What is Medtronic's deferred revenue?
Medtronic (MDT) reported deferred revenue of $400M in Q4 2025.
How has Medtronic's deferred revenue changed year-over-year?
Medtronic's deferred revenue decreased by 0.0% year-over-year, from $400M to $400M.